Bahriye Aktas Selected Research

giredestrant

2/2022

Update Breast Cancer 2021 Part 4 - Prevention and Early Stages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bahriye Aktas Research Topics

Disease

67	Breast Neoplasms (Breast Cancer) 06/2024 - 01/2009
55	Neoplasms (Cancer) 06/2024 - 01/2009
15	Circulating Neoplastic Cells 03/2021 - 06/2009
9	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2024 - 01/2013
8	Neoplasm Metastasis (Metastasis) 01/2023 - 07/2013
8	Pathologic Complete Response 01/2023 - 12/2013
8	Triple Negative Breast Neoplasms 11/2022 - 01/2020
7	Ovarian Neoplasms (Ovarian Cancer) 02/2021 - 07/2011
6	Disease Progression 01/2018 - 08/2011
5	Endometrial Neoplasms (Endometrial Cancer) 05/2017 - 01/2013
4	Uterine Neoplasms (Uterine Cancer) 04/2016 - 01/2013
2	Residual Neoplasm 09/2022 - 01/2013
1	Preterm Premature Rupture of the Membranes 05/2023
1	Premature Birth (Birth, Premature) 05/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Inflammation (Inflammations) 11/2022
1	Leiomyoma (Uterine Fibroids) 11/2022
1	Aneurysm (Aneurysms) 11/2022
1	Brain Neoplasms (Brain Tumor) 06/2022
1	Lymphatic Metastasis 04/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Compartment Syndromes 01/2020

Drug/Important Bio-Agent (IBA)

25	Hormones (Hormone)IBA 06/2023 - 08/2011
17	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2013
7	Progesterone Receptors (Progesterone Receptor)IBA 04/2022 - 01/2009
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 12/2013
5	Estrogen ReceptorsIBA 12/2021 - 01/2009
5	human ERBB2 proteinIBA 01/2021 - 03/2015
5	130-nm albumin-bound paclitaxelIBA 01/2020 - 03/2016
4	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2015
4	AnthracyclinesIBA 01/2023 - 10/2016
4	Trastuzumab (Herceptin)FDA Link 01/2023 - 12/2013
4	ErbB Receptors (EGF Receptor)IBA 01/2023 - 11/2013
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 01/2017
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 09/2017 - 04/2016
3	Letrozole (Femara)FDA LinkGeneric 02/2024 - 03/2015
3	olaparibIBA 06/2023 - 02/2021
3	Indicators and Reagents (Reagents)IBA 05/2023 - 01/2009
3	Phenobarbital (Luminal)FDA Link 01/2023 - 01/2021
3	taxaneIBA 01/2023 - 03/2016
3	Immune Checkpoint InhibitorsIBA 06/2022 - 05/2021
3	Estrogens (Estrogen)FDA Link 04/2022 - 08/2011
3	N-acetyltalosaminuronic acid (NAT)IBA 10/2021 - 01/2021
3	Carboplatin (JM8)FDA LinkGeneric 02/2021 - 10/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 03/2016
3	Epirubicin (Ellence)FDA LinkGeneric 01/2019 - 03/2016
3	AntigensIBA 12/2016 - 07/2011
3	Epithelial Cell Adhesion MoleculeIBA 01/2016 - 01/2009
3	PlatinumIBA 10/2014 - 07/2011
2	CollagenIBA 06/2024 - 01/2023
2	Aromatase InhibitorsIBA 02/2024 - 12/2021
2	Cell-Free Nucleic AcidsIBA 12/2023 - 08/2022
2	abemaciclibIBA 06/2023 - 03/2023
2	sacituzumab govitecanIBA 03/2023 - 06/2022
2	Immunoconjugates (Immunoconjugate)IBA 03/2023 - 05/2021
2	pembrolizumabIBA 03/2023 - 09/2022
2	Ado-Trastuzumab EmtansineIBA 01/2023 - 09/2017
2	trastuzumab deruxtecanIBA 09/2022 - 06/2022
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2022 - 02/2022
2	Progesterone FDA LinkGeneric 04/2022 - 01/2016
2	Gemcitabine FDA Link 01/2020 - 01/2018
2	Docetaxel (Taxotere)FDA Link 01/2019 - 10/2016
2	SolventsIBA 01/2019 - 03/2016
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2019 - 11/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 11/2018
2	RNA (Ribonucleic Acid)IBA 01/2018 - 08/2011
2	Tumor Biomarkers (Tumor Markers)IBA 12/2016 - 07/2013
2	Proteins (Proteins, Gene)FDA Link 10/2016 - 10/2014
2	Diphosphonates (Bisphosphonates)IBA 01/2016 - 07/2013
1	Local AnestheticsIBA 03/2023
1	atezolizumabIBA 03/2023
1	GelsIBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	tucatinibIBA 06/2022
1	AlpelisibIBA 06/2022
1	Epidermal Growth Factor (EGF)IBA 04/2022
1	giredestrantIBA 02/2022
1	talazoparibIBA 02/2022
1	Circulating Tumor DNAIBA 01/2022
1	Tamoxifen FDA LinkGeneric 12/2021
1	Cyclin-Dependent Kinase 4IBA 05/2021
1	Transcription Factors (Transcription Factor)IBA 02/2021
1	AlbuminsIBA 01/2019

Therapy/Procedure

34	Therapeutics 02/2024 - 01/2009
19	Drug Therapy (Chemotherapy) 01/2023 - 07/2011
16	Neoadjuvant Therapy 03/2023 - 12/2013
9	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 01/2013
6	Hysterectomy 01/2022 - 08/2013
2	Adjuvant Radiotherapy 01/2019 - 01/2016
2	Palliative Care (Palliative Therapy) 07/2016 - 08/2011
1	Traction 06/2024
1	Adjuvant Chemotherapy 01/2023
1	Endurance Training 01/2023
1	Anesthesia 11/2022
1	Surgical Instruments (Clip) 11/2022
1	Uterine Myomectomy 11/2022
1	Length of Stay 11/2022
1	Animal Assisted Therapy 12/2021
1	General Anesthesia 06/2021
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 01/2020